Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Pyzchiva

Pyzchiva 130 mg concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 7–8

HOS-151985 · Präparat HOS-100665

7 Table 3 provides a list of adverse reactions from adult psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis clinical studies as well as adverse reactions reported from post-marketing experience. The adverse reactions are classified by System Organ Class and frequency, using the following convention: Very common (≥ 1/10), Common (≥ 1/100 to < 1/10), Uncommon (≥ 1/1,000 to < 1/100), Rare (≥ 1/10,000 to < 1/1,000), Very rare (< 1/10,000), not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.